tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NBIX Stock Latest News

Evercore says failure of emraclidine ‘may’ be ‘substantial’ Neurocrine positive
The FlyEvercore says failure of emraclidine ‘may’ be ‘substantial’ Neurocrine positive
15d ago
BMY
ABBV
Neurocrine’s Ingrezza shows efficacy in Huntington’s Disease Chorea
PremiumThe Fly
Neurocrine’s Ingrezza shows efficacy in Huntington’s Disease Chorea
19d ago
NBIX
Neurocrine presents data from Ingrezza studies on tardive dyskines patients
PremiumThe Fly
Neurocrine presents data from Ingrezza studies on tardive dyskines patients
22d ago
NBIX
Neurocrine presents data from long-term KINECT-4 study
PremiumThe Fly
Neurocrine presents data from long-term KINECT-4 study
22d ago
NBIX
Neurocrine Biosciences’ $300M Share Buyback Plan: Potential Risks and Market Volatility Concerns
PremiumCompany Announcements
Neurocrine Biosciences’ $300M Share Buyback Plan: Potential Risks and Market Volatility Concerns
26d ago
NBIX
Neurocrine Biosciences Reports Strong Q3 2024 Earnings
PremiumCompany AnnouncementsNeurocrine Biosciences Reports Strong Q3 2024 Earnings
26d ago
NBIX
Neurocrine reports Q3 non-GAAP EPS $1.81, consensus $1.50
Premium
The Fly
Neurocrine reports Q3 non-GAAP EPS $1.81, consensus $1.50
27d ago
NBIX
Neurocrine sees FY24 Ingrezza revenue $2.300B-$2.320B
Premium
The Fly
Neurocrine sees FY24 Ingrezza revenue $2.300B-$2.320B
27d ago
NBIX
Neurocrine participates in a conference call with Needham
PremiumThe Fly
Neurocrine participates in a conference call with Needham
28d ago
NBIX
NBIX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NBIX Earnings this Week: How Will it Perform?
29d ago
NBIX
AbbVie price target raised to $195 from $185 at BofA
PremiumThe Fly
AbbVie price target raised to $195 from $185 at BofA
1M ago
BMY
ABBV
Neurocrine price target lowered to $114 from $128 at BMO Capital
PremiumThe Fly
Neurocrine price target lowered to $114 from $128 at BMO Capital
1M ago
NBIX
Neurocrine Biosciences Names Dr. Gano as President and CEO
PremiumCompany AnnouncementsNeurocrine Biosciences Names Dr. Gano as President and CEO
2M ago
8K
NBIX
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
2M ago
CVS
EAT
Neurocrine resumed with an Outperform at Raymond James
Premium
The Fly
Neurocrine resumed with an Outperform at Raymond James
2M ago
NBIX
Neurocrine announces interim results from ongoing KINECT-HD2 study
PremiumThe Fly
Neurocrine announces interim results from ongoing KINECT-HD2 study
2M ago
NBIX
Voyager advances Neurocrine collaboration, selects third gene therapy candidate
PremiumThe Fly
Voyager advances Neurocrine collaboration, selects third gene therapy candidate
2M ago
NBIX
VYGR
Neurocrine’s luvadaxistat did not meet primary endpoint in schizophrenia trial
PremiumThe Fly
Neurocrine’s luvadaxistat did not meet primary endpoint in schizophrenia trial
2M ago
NBIX
Competitor disappointments bode well for Neurocrine, says BofA
PremiumThe Fly
Competitor disappointments bode well for Neurocrine, says BofA
3M ago
BBIO
NBIX
Neurocrine Stock’s (NBIX) Schizophrenia Selloff Has Made It Undervalued
PremiumMarket NewsNeurocrine Stock’s (NBIX) Schizophrenia Selloff Has Made It Undervalued
3M ago
NBIX
Neurocrine price target lowered to $160 from $180 at Barclays
Premium
The Fly
Neurocrine price target lowered to $160 from $180 at Barclays
3M ago
NBIX
Election 2024: Where To Put Your Money Ahead of the Vote
Premium
The Fly
Election 2024: Where To Put Your Money Ahead of the Vote
3M ago
X
CI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >